SENEB Q1 2026 Earnings Strong EPS Performance Amidst Uncertain Market Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution NFBK Q1 2026 Earnings EPS Surpasses Estimates by 417 as Net Interest Margin Holds Steady EFX Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher YSG Q4 2025 Earnings Strong EPS Performance Lifts Stock Despite Sparse Data Onconetix Inc ONCO Q1 2025 Earnings Positive EPS Amidst Minimal Reported Revenue